Royalty Pharma plc Annual Operating Margin in % from 2018 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Royalty Pharma plc quarterly/annual Operating Margin history and growth rate from 2018 to 2024.
  • Royalty Pharma plc Operating Margin for the quarter ending December 31, 2024 was 57.1 %, a 9.91% decline year-over-year.
  • Royalty Pharma plc annual Operating Margin for 2024 was 57.1 %, a 9.91% decline from 2023.
  • Royalty Pharma plc annual Operating Margin for 2023 was 63.4 %, a 362% increase from 2022.
  • Royalty Pharma plc annual Operating Margin for 2022 was 13.7 %, a 78% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 57.1 -6.28 -9.91% Jan 1, 2024 Dec 31, 2024
2023 63.4 +49.7 +362% Jan 1, 2023 Dec 31, 2023
2022 13.7 -48.8 -78% Jan 1, 2022 Dec 31, 2022
2021 62.5 -12.7 -16.9% Jan 1, 2021 Dec 31, 2021
2020 75.2 -69.4 -48% Jan 1, 2020 Dec 31, 2020
2019 145 +68.6 +90.2% Jan 1, 2019 Dec 31, 2019
2018 76 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.